BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37365565)

  • 21. Different phenotypes of neuropsychiatric systemic lupus erythematosus are related to a distinct pattern of structural changes on brain MRI.
    Inglese F; Kant IMJ; Monahan RC; Steup-Beekman GM; Huizinga TWJ; van Buchem MA; Magro-Checa C; Ronen I; de Bresser J
    Eur Radiol; 2021 Nov; 31(11):8208-8217. PubMed ID: 33929569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pristane induced lupus mice as a model for neuropsychiatric lupus (NPSLE).
    Yun Y; Wang X; Xu J; Jin C; Chen J; Wang X; Wang J; Qin L; Yang P
    Behav Brain Funct; 2023 Feb; 19(1):3. PubMed ID: 36765366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of eye sign combined with increased interleukin-6 in cerebrospinal fluid in patients with neuropsychiatric lupus erythematosus.
    Shi LH; Liu ZY; Yu SJ; Xia Q; Zhao J; Wu R
    Int J Rheum Dis; 2023 Aug; 26(8):1464-1473. PubMed ID: 37366596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitor of NF-κB Kinase Subunit ε Contributes to Neuropsychiatric Manifestations in Lupus-Prone Mice Through Microglial Activation.
    Karino K; Kono M; Takeyama S; Kudo Y; Kanda M; Abe N; Aso K; Fujieda Y; Kato M; Oku K; Amengual O; Atsumi T
    Arthritis Rheumatol; 2023 Mar; 75(3):411-423. PubMed ID: 36098515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.
    Liang R; Zheng L; Ji T; Zheng J; Liu J; Yuan C; Huang Q; Yang M
    Lupus; 2022 Feb; 31(2):187-193. PubMed ID: 35042378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
    Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
    Front Immunol; 2018; 9():2189. PubMed ID: 30319641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
    Hirohata S; Arinuma Y; Yanagida T; Yoshio T
    Arthritis Res Ther; 2014 Mar; 16(2):R77. PubMed ID: 24655341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ectopic CD4
    Wang K; Hou X; Lu H; Han N; Xie M; Xi A; Xu Z
    J Autoimmun; 2024 May; 145():103199. PubMed ID: 38452512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
    Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
    Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement.
    Cohen D; Rijnink EC; Nabuurs RJ; Steup-Beekman GM; Versluis MJ; Emmer BJ; Zandbergen M; van Buchem MA; Allaart CF; Wolterbeek R; Bruijn JA; van Duinen SG; Huizinga TW; Bajema IM
    Rheumatology (Oxford); 2017 Jan; 56(1):77-86. PubMed ID: 28028157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diminished white matter integrity in patients with systemic lupus erythematosus.
    Schmidt-Wilcke T; Cagnoli P; Wang P; Schultz T; Lotz A; Mccune WJ; Sundgren PC
    Neuroimage Clin; 2014; 5():291-7. PubMed ID: 25161895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation between proteoglycan 2 and neuropsychiatric systemic lupus erythematosus.
    Qiao X; Lu L; Zhou K; Tan L; Liu X; Ni J; Hou Y; Liang J; Dou H
    Clin Immunol; 2022 Jun; 239():109042. PubMed ID: 35568106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population--a preliminary report.
    Bogaczewicz A; Sobow T; Bogaczewicz J; Kaleta B; Sysa-Jedrzejowska A; Robak E; Lukaszkiewicz J; Dariusz S; Wozniacka A
    Lupus; 2013 Dec; 22(14):1504-8. PubMed ID: 24243911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative susceptibility mapping in the thalamus and basal ganglia of systemic lupus erythematosus patients with neuropsychiatric complaints.
    Bulk M; van Harten T; Kenkhuis B; Inglese F; Hegeman I; van Duinen S; Ercan E; Magro-Checa C; Goeman J; Mawrin C; van Buchem M; Steup-Beekman G; Huizinga T; van der Weerd L; Ronen I
    Neuroimage Clin; 2021; 30():102637. PubMed ID: 33812303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of osteopontin in cerebrospinal fluid as a diagnostic marker for neuropsychiatric systemic lupus erythematosus.
    Kitagori K; Yoshifuji H; Oku T; Ayaki T; Kuzuya A; Nakajima T; Akizuki S; Nakashima R; Murakami K; Ohmura K; Hirayama Y; Takahashi R; Mimori T
    Lupus; 2019 Mar; 28(3):414-422. PubMed ID: 30744522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of microRNA-762 suppresses the expression of GIPC3 in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus.
    Yang J; Li C; Chi S; Wei H; Du W; Hu Q
    Immun Inflamm Dis; 2022 Nov; 10(11):e719. PubMed ID: 36301034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus.
    Mike EV; Makinde HM; Gulinello M; Vanarsa K; Herlitz L; Gadhvi G; Winter DR; Mohan C; Hanly JG; Mok CC; Cuda CM; Putterman C
    J Autoimmun; 2019 Jan; 96():59-73. PubMed ID: 30174216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.